News

UH Researcher Developing New Device to Treat Babies with Blood Disorders

By: 

Laurie Fickman 713-743-8454
Biomedical engineering professor Sergey Shevkoplyas  is using a $1.6 million grant from the National Heart, Lung, and Blood Institute, to adapt microfluidic technology to enable leukapheresis in babies.
Biomedical engineering professor Sergey Shevkoplyas is using a $1.6 million grant from the National Heart, Lung, and Blood Institute, to adapt microfluidic technology to enable leukapheresis in babies.

With severe blood disorders, such as leukemia, doctors often rely on leukapheresis, a procedure in which large machines extract whole blood from patients to separate white blood cells from the rest of the blood, which is then returned back to the patient. This procedure is generally used to urgently reduce a dangerously elevated white blood cell count, or to collect various white blood cell subsets for therapeutic purposes. 

“Although well-tolerated by most adults and older children, leukapheresis in young children, weighing less than about 22 pounds, is technically challenging and clinically risky,” said biomedical engineering professor Sergey Shevkoplyas who has been awarded $1.6 million from the National Heart, Lung, and Blood Institute to develop pediatric-sized technology. Baylor College of Medicine collaborators include Fong W. Lam and Karen R. Rabin. 

Leukapheresis is currently performed using centrifugation-based machines, which require a substantial amount of blood be taken out of a patient, putting small children at significantly higher risk of low blood pressure, catheter-related thrombosis, infections, severe anemia and even death. 

Shevkoplyas is developing a new device that looks like a small plastic dish with many tiny channels cut into it.  The channels are designed to separate blood cells by size, using a new cell separation approach called controlled incremental filtration (CIF). He and his colleagues are planning to adapt CIF to enable separation of white blood cells from flowing blood with high efficiency, minimal loss of red blood cells and platelets, and at flow rates on par with conventional leukapheresis. 

“The ability to perform leukapheresis safely and effectively in these most vulnerable pediatric patients will significantly increase their access to a rapidly expanding range of highly effective cell-based therapies, thus having a potentially transformative impact on health and well-being of children worldwide.” 

“Since all the existing machines were built for adults, we have to do something very special for babies, that’s what is inspiring us,” Shevkoplyas said. 

Faculty: 

Department/Academic Programs: 

Related News Stories

New Technology Could Improve LASIK Surgery, Eye Disease Detection

Dr. Kirill Larin, University of Houston professor of biomedical engineering, is creating new technology to measure the elasticity of the cornea.

UH Professor to Create Ultrafast 3D Clinical Imaging System

LASIK eye surgery – a laser reshaping of the cornea to improve vision – is one of the most popular elective surgeries in the United States, and a University of Houston professor of biomedical engineering intends to improve upon it by giving surgeons more information about the cornea before they begin.  

Nearing a Treatment for Farsightedness

Kirill Larin, professor of biomedical engineering, has received $3 million from the National Eye Institute to create a new technology capable of precise noninvasive and depth-resolved quantitative measurements of the lens mechanical properties in a clinical setting.

UH Professor Developing New Technology to Detect Lens Elasticity

A biomedical researcher at the University of Houston's Cullen College of Engineering is developing new technology that will measure the stiffness of the lens in the eye, which is likely associated with presbyopia, or farsightedness, the inevitable and age-related loss of the ability to focus on nearby objects.